Orexigen Therapeutics
In Seth Klarman's portfolio · Baupost Group
Ticker OREX
Not in the portfolio as of Q3 2026. Every quarter it shows up in a Baupost Group 13F, newest first.
| Quarter | Activity | Shares | Weight |
|---|---|---|---|
| Q2 2018 | Sell | 0 | |
| Q1 2018 | No change | 2,226,839 | 0.0% |
| Q4 2017 | No change | 2,226,839 | 0.0% |
| Q3 2017 | No change | 2,226,839 | 0.1% |
| Q2 2017 | No change | 2,226,839 | 0.1% |
| Q1 2017 | No change | 2,226,839 | 0.1% |
| Q4 2016 | No change | 2,226,839 | 0.1% |
| Q3 2016 | Reduce 90% | 2,226,839 | 0.1% |
| Q2 2016 | No change | 22,268,399 | 0.1% |
| Q1 2016 | Add 882% | 22,268,399 | 0.2% |
| Q4 2015 | Add 176% | 2,268,399 | 0.1% |
| Q3 2015 | Buy | 821,363 | 0.0% |
Price is the position's value divided by its shares, at the end of each quarter. Share counts are as filed; when a stock split happened, the change is measured on split-adjusted shares.